Europe and Middle East Spinal Cord Stimulation Devices for Chronic Pain Market Size and Forecasts (2020 – 2030)

Europe and Middle East Spinal Cord Stimulation Devices for Chronic Pain Market Size and Forecasts (2020 – 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type (Rechargeable and Non-Rechargeable), Application (Failed Back Syndrome, Complex Regional Pain Syndrome, Degenerative Disk Disease, and Others), End User [Hospitals, Ambulatory Surgery Centers (ASCs), and Others], and Regional Analysis

Send Enquiry
Item ID: TIPRE00030317 Category: Tags: , ,

$2,415$3,885

Description

The Europe and Middle East spinal cord stimulation devices for chronic pain market is expected to grow from US$ 0.892 billion in 2022 to US$ 1.573 billion by 2030; it is expected to grow at a CAGR of 7.3% from 2022 to 2030. rising number of spinal cord injuries and the availability of innovative treatments in the European Union (EU) are a few factors driving the Europe and Middle East spinal cord stimulation devices for chronic pain market growth.
A spinal cord stimulation device is an implanted device that sends low levels of electricity directly into the spinal cord to relieve pain. A spinal cord stimulator is mostly used after non-surgical pain treatment options that have failed to provide sufficient relief. Additionally, a spinal cord stimulator can improve the overall quality of life and sleep and reduce the need for pain medicines. It is typically used along with other pain management treatments.
Availability of Innovative Treatments in the European Union
According to a report published by the European Commission, SCI is responsible for causing motor impairment with sensation loss, chronic pain, and other locomotor dysfunction. Therefore, in the European Union (EU), several rehabilitation programs are being conducted for patients living with SCIs. The SPINAL CORD REPAIR Project (SCRP) is one such example that is a multidisciplinary collaboration among EU scientists. The SCRP is responsible for restoring physical movements such as motor function or movement after SCIs. Under this program, an experimental setup—MotoRater—was developed and trademarked for the standardized testing of locomotion movements among rodents as a part of clinical testing. These rodents were utilized to identify and characterize the cellular properties of excitatory central pattern generator (CPG) neurons such as EphA4, which are responsible for locomotion. CPG is a neural circuit in the spinal cord that stimulates rhythmic movements from the interplay between CPG neurons and their synaptic interactions. The clinical research results were presented through meetings and congresses; patents were filed and published. Therefore, the ongoing innovations in the treatments of spinal cord disorders in the EU help improve the mobility and quality of life for millions suffering from SCI.
Several biopharma companies are developing innovative products to treat SCIs. BioArctic, a Swedish biopharma company, is dedicated to developing treatments for central nervous system (CNS) disorders. For instance, in February 2019, BioArctic developed “SC0806,” a biodegradable medical device that is surgically implanted into an injured spinal cord. Upon the implantation of “SCO806,” the device guides nerve fibers across the injured area in the spinal cord. Such innovative product launches by competitive players to treat SCI fuel the growth of spinal cord stimulation devices for the chronic pain market in Europe and the Middle East.
?
Market Trend
Regenerative and Innovative Implant-Based Therapeutic Approaches
The Comunidad de Madrid claims to be the first in the EU to provide treatments for SCIs using cell and regenerative therapy. Regenerative medicine includes the extraction of mesenchymal stem cells from patients suffering SCIs, treating the extracted cells in a cell production room, and then injecting the regenerated cells at the exact site of SCI or into the cerebrospinal fluid (CSF). Thus, this technique serves as a personalized treatment for SCIs.
The European Commission published a report in September 2022 revealing that scientists are developing new ways to treat SCI using graphene-based implants and virtual reality (VR) gaming to help improve stroke recovery. Scientists are trying these new approaches to reverse nerve damage, while some researchers are attempting to reshape the architecture of the spinal cord in situ by using engineered materials such as graphene. Graphene is used to create a 3D structure that would skillfully mimic the morphology of the spinal cord. Therefore, the use of such innovative engineered materials and implants successfully exhibits the treatment potential in patients suffering from SCIs. The regenerative and innovative implant-based therapeutic approaches are emerging as new trends in Europe and the Middle East spinal cord stimulation devices for the chronic pain market.
The “Europe and Middle East Spinal Cord Stimulation Devices for Chronic Pain Market” is segmented on the basis of product type, application, end-user, and region. Based on product type, the spinal cord stimulation devices for chronic pain market is bifurcated into rechargeable and non-rechargeable. The rechargeable segment held the largest market share in 2022, and the same segment is expected to record a significant CAGR during 2022–2030. Based on application, the spinal cord stimulation devices for the chronic pain market are segmented as failed back syndrome, complex regional pain syndrome, degenerative disk disease, and others. The complex regional pain syndrome segment held the largest market share in 2022, and the same segment is anticipated to register the highest CAGR for the forecast period 2020-2030. In terms of end users, the spinal cord stimulation devices for the chronic pain market are categorized into hospitals, ambulatory surgery centers, and others. The hospital segment held a larger share of the market in 2022 and is anticipated to register a higher CAGR during 2022–2030.
In September 2023, Resonant Link and Cirtec Medical Corp partnered to power the future of implantable medical devices. By combining Resonant Link’s next-generation wireless power with Cirtec Medical’s expert product design, development, and manufacturing services, this partnership will offer medical device makers the best technology, fully integrated components, and faster time to market.

Summary Info

Industry:

Number of pages:

Pricing options:

, ,

Publishing status:

Geographical coverage:

Year of Publication:

According to our new research study on “Europe and Middle East Spinal Cord Stimulation Devices for Chronic Pain Market Forecast to 2030 Regional Analysis – by Product Type, Application, End User, and Region,” the Europe and Middle East spinal cord stimulation devices for chronic pain market is expected to grow from US$ 0.892 billion in 2022 to US$ 1.573 billion by 2030; it is estimated to register a CAGR of 7.3% during the forecast period. The rising number of spinal cord injuries and the availability of innovative treatments in the European Union (EU) are the major factors contributing to the market growth.

Rising Number of Spinal Cord Injuries

According to a report published by the Association for Spinal Injury Research, Rehabilitation and Reintegration (Aspire, UK), ~2,500 people are diagnosed with spinal cord injuries (SCIs) annually in the UK. Currently, ~50,000 people are living with SCIs in the country. An elevated number of cases is attributed to emerging motocross and motorcycling competitions as the most popular sporting activities in the UK, as per the National Institute of Health (NIH) report. With rising motor sporting activities among the youth and senior age group population, there is an increase in the incidence of SCIs among the participants of these events. SCIs have life-changing impacts on the injured patients and their families. The rising incidence of SCIs, results in at least one readmission of the patient every year. This is because SCIs are not treated at once. The causes of rehospitalization include respiratory and urinary tract infections and fractures occurring during motorcycling sports activities.
The London Spinal Cord Injury Center (LSCIC) is 1 of the 11 organizations in the UK dedicated to treating SCI patients. At the LSCIC, patients undergo a rehabilitation program that takes years and is best delivered through lifelong intervention. With rising SCI and the availability of a well-developed infrastructure in treatment centers providing rehabilitation programs, demand for spinal cord stimulation devices is surging in specialized or rehab centers, which fuels the market growth.

?
Future Trend
Regenerative and Innovative Implant-Based Therapeutic Approaches
The Comunidad de Madrid claims to be the first in the EU to provide treatments for SCIs using cell and regenerative therapy. Regenerative medicine includes the extraction of mesenchymal stem cells from patients suffering SCIs, treating the extracted cells in a cell production room, and then injecting the regenerated cells at the exact site of SCI or into the cerebrospinal fluid (CSF). Thus, this technique serves as a personalized treatment for SCIs.
The European Commission published a report in September 2022 revealing that scientists are developing new ways to treat SCI using graphene-based implants and virtual reality (VR) gaming to help improve stroke recovery. Scientists are trying these new approaches to reverse nerve damage, while some researchers are attempting to reshape the architecture of the spinal cord in situ by using engineered materials such as graphene. Graphene is used to create a 3D structure that would skillfully mimic the morphology of the spinal cord. Therefore, the use of such innovative engineered materials and implants successfully exhibits the treatment potential in patients suffering from SCIs. The regenerative and innovative implant-based therapeutic approaches are emerging as new trends in Europe and the Middle East for spinal cord stimulation devices for the chronic pain market.

Boston Scientific Corp, Abbott Laboratories, Medtronic Plc, Curonix LLC, Biotronik SE & Co KG, Nevro Corp, Nalu Medical Inc, Cirtec Medical Corp, and Synapse Biomedical Inc are among the leading companies operating in the Europe and Middle East spinal cord stimulation devices for chronic pain market.

?
The “Europe and Middle East Spinal Cord Stimulation Devices for Chronic Pain Market” is segmented on the basis of product type, application, end-user, and region. Based on product type, the spinal cord stimulation devices for chronic pain market is bifurcated into rechargeable and non-rechargeable. The rechargeable segment held the largest market share in 2022, and the same segment is expected to record a significant CAGR during 2022–2030. Based on application, the spinal cord stimulation devices for the chronic pain market are segmented as failed back syndrome, complex regional pain syndrome, degenerative disk disease, and others. The complex regional pain syndrome segment held the largest market share in 2022, and the same segment is anticipated to register the highest CAGR for the forecast period 2020-2030. In terms of end users, the spinal cord stimulation devices for the chronic pain market are categorized into hospitals, ambulatory surgery centers, and others. The hospital segment held a larger share of the market in 2022 and is anticipated to register a higher CAGR during 2022–2030.

?

– Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific frozen waffles market.
– Highlights key business priorities in order to assist companies to realign their business strategies.
– the key findings and recommendations highlight crucial progressive industry trends in Asia Pacific frozen waffles market, thereby allowing players across the value chain to develop effective long-term strategies.
– develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
– Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
– Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 Study Scope
1.2 Research Report Guidance
1.3 Market Segmentation
2. Key Takeaways
3. Research Methodology
3.1 Scope of the Study
3.2 Research Methodology
3.2.1 Data Collection:
3.2.2 Primary Interviews:
3.2.3 Hypothesis Formulation:
3.2.4 Macro-economic Factor Analysis:
3.2.5 Developing Base Number:
3.2.6 Data Triangulation:
3.2.7 Country Level Data:
3.2.8 Limitations and Assumptions
4. Asia Pacific Human Milk Fortifier Market Landscape
4.1 Market Overview
4.2 Porter’s Five Forces Analysis
4.2.1 Threat of New Entrants:
4.2.2 Bargaining Power of Buyers:
4.2.3 Bargaining Power of Suppliers:
4.2.4 Intensity of Competitive Rivalry:
4.2.5 Threat of Substitutes:
4.3 Expert Opinion
5. Asia Pacific Human Milk Fortifier Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increase in Number of Preterm Births
5.1.2 Strategic Initiatives by Key Market Players
5.2 Market Restraints
5.2.1 Lack of Awareness among Parents and Caregivers
5.3 Market Opportunities
5.3.1 Rising Awareness in Developing Countries
5.4 Future Trends
5.4.1 New Ways of Feeding Fortifiers to Infants
5.5 Impact Analysis of Drivers and Restraints
6. Human Milk Fortifier – Asia Pacific Market Analysis
6.1 Asia Pacific Human Milk Fortifier Market –Revenue and Forecast to 2030 (US$ Million)
7. Asia Pacific Human Milk Fortifier Market Analysis – By Form
7.1 Overview
7.2 Human Milk Fortifier Market, By Form (2022 and 2030)
7.3 Powder
7.3.1 Overview
7.3.2 Powder: Human Milk Fortifier Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Liquid
7.4.1 Overview
7.4.2 Liquid: Human Milk Fortifier Market – Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Human Milk Fortifier Market Analysis – By Distribution Channel
8.1 Overview
8.2 Human Milk Fortifier Market, By Distribution Channel (2022 and 2030)
8.3 Online
8.3.1 Overview
8.3.2 Online: Human Milk Fortifier Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Offline
8.4.1 Overview
8.4.2 Offline: Human Milk Fortifier Market – Revenue and Forecast to 2030 (US$ Million)
9. Asia Pacific Human Milk Fortifier Market – by Country Analysis
9.1 Asia Pacific: Human Milk Fortifier Market
9.1.1 Asia Pacific: Human Milk Fortifier Market, by Key Country
9.1.1.1 Australia: Human Milk Fortifier Market –Revenue and Forecast to 2030 (US$ Million)
9.1.1.1.1 Australia: Human Milk Fortifier Market, by Form
9.1.1.1.2 Australia: Human Milk Fortifier Market, by Distribution Channel
9.1.1.2 China: Human Milk Fortifier Market –Revenue and Forecast to 2030 (US$ Million)
9.1.1.2.1 China: Human Milk Fortifier Market, by Form
9.1.1.2.2 China: Human Milk Fortifier Market, by Distribution Channel
9.1.1.3 India: Human Milk Fortifier Market –Revenue and Forecast to 2030 (US$ Million)
9.1.1.3.1 India: Human Milk Fortifier Market, by Form
9.1.1.3.2 India: Human Milk Fortifier Market, by Distribution Channel
9.1.1.4 Japan: Human Milk Fortifier Market –Revenue and Forecast to 2030 (US$ Million)
9.1.1.4.1 Japan: Human Milk Fortifier Market, by Form
9.1.1.4.2 Japan: Human Milk Fortifier Market, by Distribution Channel
9.1.1.5 South Korea: Human Milk Fortifier Market –Revenue and Forecast to 2030 (US$ Million)
9.1.1.5.1 South Korea: Human Milk Fortifier Market, by Form
9.1.1.5.2 South Korea: Human Milk Fortifier Market, by Distribution Channel
9.1.1.6 Rest of Asia Pacific: Human Milk Fortifier Market –Revenue and Forecast to 2030 (US$ Million)
9.1.1.6.1 Rest of Asia Pacific: Human Milk Fortifier Market, by Form
9.1.1.6.2 Rest of Asia Pacific: Human Milk Fortifier Market, by Distribution Channel
10. Company Profiles
10.1 Abbott Laboratories
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 NeoLacta Lifesciences Pvt Ltd
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Nestle SA
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Prolacta Bioscience Inc
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Lead Care International Ltd
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 Raptakos, Brett & Co Ltd
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Danone SA
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Reckitt Benckiser Group Plc
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
11. Appendix
11.1 About
11.2 Word Index

LIST OF TABLES

Table 1. Surgical Navigation Systems Market Segmentation
Table 2. Europe: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type
Table 3. Europe: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – Application
Table 4. Europe: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 5. Germany: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type
Table 6. Germany: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – Application
Table 7. Germany: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 8. France: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type
Table 9. France: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – Application
Table 10. France: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 11. Italy: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type
Table 12. Italy: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – Application
Table 13. Italy: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 14. Spain: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type
Table 15. Spain: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – Application
Table 16. Spain: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 17. United Kingdom: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type
Table 18. United Kingdom: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – Application
Table 19. United Kingdom: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 20. Switzerland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type
Table 21. Switzerland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – Application
Table 22. Switzerland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 23. Netherlands: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type
Table 24. Netherlands: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – Application
Table 25. Netherlands: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 26. Sweden: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type
Table 27. Sweden: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – Application
Table 28. Sweden: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 29. Belgium: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type
Table 30. Belgium: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – Application
Table 31. Belgium: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 32. Poland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type
Table 33. Poland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – Application
Table 34. Poland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 35. Slovakia: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type
Table 36. Slovakia: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – Application
Table 37. Slovakia: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 38. Czech Republic: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type
Table 39. Czech Republic: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – Application
Table 40. Czech Republic: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 41. Greece: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type
Table 42. Greece: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – Application
Table 43. Greece: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 44. Ireland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type
Table 45. Ireland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – Application
Table 46. Ireland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 47. Rest of Europe: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type
Table 48. Rest of Europe: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – Application
Table 49. Rest of Europe: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 50. Middle East: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type
Table 51. Middle East: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – Application
Table 52. Middle East: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 53. Qatar: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type
Table 54. Qatar: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – Application
Table 55. Qatar: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 56. Saudi Arabia: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type
Table 57. Saudi Arabia: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – Application
Table 58. Saudi Arabia: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 59. UAE: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type
Table 60. UAE: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – Application
Table 61. UAE: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 62. Turkey: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type
Table 63. Turkey: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – Application
Table 64. Turkey: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 65. Israel: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type
Table 66. Israel: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – Application
Table 67. Israel: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 68. Rest of Middle East: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type
Table 69. Rest of Middle East: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – Application
Table 70. Rest of Middle East: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 71. Organic Developments Done By Companies
Table 72. Inorganic Developments Done By Companies
Table 73. Glossary of Terms

LIST OF FIGURES

Figure 1. Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market, by Region
Figure 2. Key Insights
Figure 3. Europe and Middle East: PEST Analysis
Figure 4. Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market- Key Industry Dynamics
Figure 5. Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market: Impact Analysis of Drivers and Restraints
Figure 6. Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market – Revenue Forecast and Analysis – 2021–2030
Figure 7. Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market Revenue Share, by Product Type, 2022 & 2030 (%)
Figure 8. Rechargeable: Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Non-Rechargeable: Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market Revenue Share, by Application (2022 and 2030)
Figure 11. Failed Back Syndrome: Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Complex Regional Pain Syndrome: Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Degenerative Disk Disease: Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market Revenue Share, by End User (2022 and 2030)
Figure 16. Hospitals: Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Ambulatory Surgery Centers (ASCs): Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Others: Europe and Middle East Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Spinal Cord Stimulation Device for Chronic Pain Market, 2022 ($Mn)
Figure 20. Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
Figure 21. Europe: Spinal Cord Stimulation Device for Chronic Pain Market, By Key Countries, 2022 And 2030 (%)
Figure 22. Germany: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
Figure 23. France: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
Figure 24. Italy: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
Figure 25. Spain: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
Figure 26. United Kingdom: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. Switzerland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. Netherlands: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
Figure 29. Sweden: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
Figure 30. Belgium: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
Figure 31. Poland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
Figure 32. Slovakia: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
Figure 33. Czech Republic: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
Figure 34. Greece: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
Figure 35. Ireland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
Figure 36. Rest of Europe: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
Figure 37. Spinal Cord Stimulation Device for Chronic Pain Market, 2022 ($Mn)
Figure 38. Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
Figure 39. Middle East: Spinal Cord Stimulation Device for Chronic Pain Market, By Key Countries, 2022 And 2030 (%)
Figure 40. Qatar: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
Figure 41. Saudi Arabia: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
Figure 42. UAE: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
Figure 43. Turkey: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
Figure 44. Israel: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
Figure 45. Rest of Middle East: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
Figure 46. Growth Strategies Done by the Companies in the Market (%)

The List of Companies – Europe and Middle East Spinal Cord Stimulation Devices for Chronic Pain Market
– Boston Scientific Corp
– Abbott Laboratories
– Medtronic Plc
– Curonix LLC
– Biotronik SE & Co KG
– Nevro Corp
– Nalu Medical Inc  
– Cirtec Medical Corp
– Synapse Biomedical Inc

Reviews

There are no reviews yet.

Be the first to review “Europe and Middle East Spinal Cord Stimulation Devices for Chronic Pain Market Size and Forecasts (2020 – 2030)”